Quick Takeaways
- Ayala Pharmaceuticals, Inc. filed SCHEDULE 13G for OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX).
- Disclosed ownership: 10%.
- Date of event: 09 Apr 2025.
Ayala Pharmaceuticals, Inc. - 09 Apr 2025 SCHEDULE 13G Report for OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX)
- Filing Manager
- Ayala Pharmaceuticals, Inc.
- Reporting Manager
- AYALA PHARMACEUTICALS, INC.
- Symbol
- OSTX
- Shares outstanding
- 21,663,814 shares
- Disclosed Ownership
- 2,164,215 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 16 Apr 2025, 14:51:33 UTC
- Date of event
- 09 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ayala Pharmaceuticals, Inc. disclosed 10% ownership in OS Therapies Incorporated Common Stock, par value $0.001 per share (OSTX) on 09 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Apr 2025, 14:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AYALA PHARMACEUTICALS, INC. | 10% | 2,164,215 | 2,164,215 | 0 | /s/ Sarit Steinberg | Sarit Steinberg /President |